About: Steven A Kaplan

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Steven A Kaplan Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) 연구원 (ko) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) باحت (ary) изилдөөчү (ky)
rdfs:label	Steven A Kaplan (en) Steven A Kaplan (nl) Steven A Kaplan (pt) Steven A Kaplan (pt-br)
skos:prefLabel	Steven A Kaplan (en) Steven A Kaplan (nl) Steven A Kaplan (pt) Steven A Kaplan (pt-br)
name	Steven A Kaplan (en) Steven A Kaplan (nl) Steven A Kaplan (pt) Steven A Kaplan (pt-br)
given name	wds:Q88176270-61513294-BE8B-49CC-9A4D-5DB95016504A
given name	Steven
instance of	wds:Q88176270-45C8F0DA-4D85-435D-A2A9-4F22EF137E22
instance of	Homo sapiens
skos:altLabel	Steven Kaplan (en)
occupation	wds:Q88176270-A2932C83-1958-441E-9DC2-51C983F45299
employer	wds:Q88176270-62F643DB-CFA7-4064-8CFD-7710467DF174
sex or gender	wds:Q88176270-AD7A8912-A99D-41CD-BEC0-6CFD10841337
VIAF ID	wds:Q88176270-5fe15a21-233d-4321-8a7f-ba00c6a5b904
IdRef ID	wds:Q88176270-4580A5FB-D3DE-40C5-BDA4-F1CC0EBECA49
family name	wds:q88176270-63e7eeb6-4d45-3726-dc37-ab32312967d3
National Library of Israel J9U ID	wds:Q88176270-F4D4C879-B381-4BA7-8B77-C144F861610E
VIAF ID	http://viaf.org/viaf/73208020
IdRef ID	http://www.idref.fr/115677828/id
occupation	researcher
employer	Icahn School of Medicine at Mount Sinai
sex or gender	male
VIAF ID	73208020
IdRef ID	115677828
family name	Kaplan
National Library of Israel J9U ID	987007380849505171
ORCID iD	wds:Q88176270-C6F049CF-6FA8-4CC1-90A9-170338F9255E
ORCID iD	https://orcid.org/0000-0003-2558-7306
ORCID iD	0000-0003-2558-7306
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q88176270
is author of	Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial Non-surgical adult male circumcision using the PrePex device: task-shifting from physicians to nurses Factors in Predicting Failure with Medical Therapy for BPH High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates Transurethral resection of the prostate: the new old standard Laser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach. Decreasing electrosurgical transurethral resection of the prostate surgical volume during graduate medical education training is associated with increased surgical adverse events Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype The prostate urethral lift: will it be uplifting or downgraded as a treatment strategy for benign prostatic hyperplasia? Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction. Diagnosis, Evaluation, and Treatment of Mixed Urinary Incontinence in Women. Photoselective laser vaporization prostatectomy in men receiving anticoagulants Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms Efficacy and safety of tolterodine extended release and dutasteride in male overactive bladder patients with prostates >30 grams Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Are stents still a useful therapy for benign prostatic hyperplasia? One-arm, open-label, prospective, cohort field study to assess the safety and efficacy of the PrePex device for scale-up of nonsurgical circumcision when performed by nurses in resource-limited settings for HIV prevention A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome Use and risks of surgical mesh for pelvic organ prolapse surgery in women in New York state: population based cohort study HIV prevention: male circumcision comparison between a nonsurgical device to a surgical technique in resource-limited settings: a prospective, randomized, nonmasked trial. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? Open to debate. The motion: PDE5 inhibitors will have a significant role in the treatment of BPH. Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder Update on AUA guideline on the management of benign prostatic hyperplasia Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. Re: Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia. Using text messaging to assess adolescents' health information needs: an ecological momentary assessment Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Male pelvic health: a urological call to arms Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia Lower urinary tract symptoms revisited: a broader clinical perspective The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms. Cost effectiveness model comparing trimethoprim sulfamethoxazole and ciprofloxacin for the treatment of chronic bacterial prostatitis Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS). Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment? Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software